123 related articles for article (PubMed ID: 22882535)
1. Variations in testosterone pathway genes and susceptibility to testicular cancer in Norwegian men.
Kristiansen W; Aschim EL; Andersen JM; Witczak O; Fosså SD; Haugen TB
Int J Androl; 2012 Dec; 35(6):819-827. PubMed ID: 22882535
[TBL] [Abstract][Full Text] [Related]
2. Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones.
Aschim EL; Oldenburg J; Kristiansen W; Giwercman A; Witczak O; Fosså SD; Haugen TB
Hum Reprod; 2014 Dec; 29(12):2844-51. PubMed ID: 25336703
[TBL] [Abstract][Full Text] [Related]
3. Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.
Rył A; Rotter I; Grzywacz A; Małecka I; Skonieczna-Żydecka K; Grzesiak K; Słojewski M; Szylińska A; Sipak-Szmigiel O; Piasecka M; Walczakiewicz K; Laszczyńska M
Int J Environ Res Public Health; 2017 Oct; 14(11):. PubMed ID: 29084161
[No Abstract] [Full Text] [Related]
4. CYP1A1, CYP3A5 and CYP3A7 polymorphisms and testicular cancer susceptibility.
Kristiansen W; Haugen TB; Witczak O; Andersen JM; Fosså SD; Aschim EL
Int J Androl; 2011 Feb; 34(1):77-83. PubMed ID: 20345875
[TBL] [Abstract][Full Text] [Related]
5. Single-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors.
Boer H; Westerink NL; Altena R; Nuver J; Dijck-Brouwer DAJ; van Faassen M; Klont F; Kema IP; Lefrandt JD; Zwart N; Boezen HM; Smit AJ; Meijer C; Gietema JA
Eur J Cancer; 2016 Feb; 54():104-111. PubMed ID: 26751392
[TBL] [Abstract][Full Text] [Related]
6. Novel mutations of the SRD5A2 and AR genes in Thai patients with 46, XY disorders of sex development.
Ittiwut C; Pratuangdejkul J; Supornsilchai V; Muensri S; Hiranras Y; Sahakitrungruang T; Watcharasindhu S; Suphapeetiporn K; Shotelersuk V
J Pediatr Endocrinol Metab; 2017 Jan; 30(1):19-26. PubMed ID: 27849622
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor polymorphisms and testicular cancer risk.
Grassetti D; Giannandrea F; Paoli D; Masciandaro P; Figura V; Carlini T; Rizzo F; Lombardo F; Lenzi A; Gandini L
Andrology; 2015 Jan; 3(1):27-33. PubMed ID: 25180665
[TBL] [Abstract][Full Text] [Related]
8. Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men.
Yu MW; Yang YC; Yang SY; Cheng SW; Liaw YF; Lin SM; Chen CJ
J Natl Cancer Inst; 2001 Nov; 93(21):1644-51. PubMed ID: 11698569
[TBL] [Abstract][Full Text] [Related]
9. Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population.
Kristiansen W; Andreassen KE; Karlsson R; Aschim EL; Bremnes RM; Dahl O; Fosså SD; Klepp O; Langberg CW; Solberg A; Tretli S; Adami HO; Wiklund F; Grotmol T; Haugen TB
Hum Reprod; 2012 May; 27(5):1525-35. PubMed ID: 22402210
[TBL] [Abstract][Full Text] [Related]
10. SRD5A gene polymorphism in Japanese men predicts prognosis of metastatic prostate cancer with androgen-deprivation therapy.
Shiota M; Fujimoto N; Yokomizo A; Takeuchi A; Itsumi M; Inokuchi J; Tatsugami K; Uchiumi T; Naito S
Eur J Cancer; 2015 Sep; 51(14):1962-9. PubMed ID: 26169017
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and molecular genetics of complete androgen insensitivity syndrome patients: a series study of 30 cases from a Chinese tertiary medical center.
Zhang D; Yao F; Tian T; Deng S; Luo M; Tian Q
Fertil Steril; 2021 May; 115(5):1270-1279. PubMed ID: 33602557
[TBL] [Abstract][Full Text] [Related]
12. NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance.
Austin DC; Strand DW; Love HL; Franco OE; Grabowska MM; Miller NL; Hameed O; Clark PE; Matusik RJ; Jin RJ; Hayward SW
Prostate; 2016 Aug; 76(11):1004-18. PubMed ID: 27197599
[TBL] [Abstract][Full Text] [Related]
13. Molecular investigation of mutations in androgen receptor and 5-alpha-reductase-2 genes in 46,XY Disorders of Sex Development with normal testicular development.
Ahmadifard M; Kajbafzadeh A; Panjeh-Shahi S; Vand-Rajabpour F; Ahmadi-Beni R; Arshadi H; Setoodeh A; Rostami P; Tavakkoly-Bazzaz J; Tabrizi M
Andrologia; 2019 Jun; 51(5):e13250. PubMed ID: 30815925
[TBL] [Abstract][Full Text] [Related]
14. Association of prostate cancer risk and aggressiveness to androgen pathway genes: SRD5A2, CYP17, and the AR.
Cicek MS; Conti DV; Curran A; Neville PJ; Paris PL; Casey G; Witte JS
Prostate; 2004 Apr; 59(1):69-76. PubMed ID: 14991867
[TBL] [Abstract][Full Text] [Related]
15. Profiles of 5α-Reduced Androgens in Humans and Eels: 5α-Dihydrotestosterone and 11-Ketodihydrotestosterone Are Active Androgens Produced in Eel Gonads.
Yazawa T; Inaba H; Imamichi Y; Sekiguchi T; Uwada J; Islam MS; Orisaka M; Mikami D; Ida T; Sato T; Miyashiro Y; Takahashi S; Khan MRI; Suzuki N; Umezawa A; Kitano T
Front Endocrinol (Lausanne); 2021; 12():657360. PubMed ID: 33833737
[TBL] [Abstract][Full Text] [Related]
16. Mutations in
Akcan N; Uyguner O; Baş F; Altunoğlu U; Toksoy G; Karaman B; Avcı Ş; Yavaş Abalı Z; Poyrazoğlu Ş; Aghayev A; Karaman V; Bundak R; Başaran S; Darendeliler F
J Clin Res Pediatr Endocrinol; 2022 Jun; 14(2):153-171. PubMed ID: 35135181
[TBL] [Abstract][Full Text] [Related]
17. The association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in men.
Allen NE; Forrest MS; Key TJ
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):185-9. PubMed ID: 11303586
[TBL] [Abstract][Full Text] [Related]
18. Testicular histological and immunohistochemical aspects in a post-pubertal patient with 5 alpha-reductase type 2 deficiency: case report and review of the literature in a perspective of evaluation of potential fertility of these patients.
Vija L; Ferlicot S; Paun D; Bry-Gauillard H; Berdan G; Abd-Alsamad I; Lombès M; Young J
BMC Endocr Disord; 2014 May; 14():43. PubMed ID: 24885102
[TBL] [Abstract][Full Text] [Related]
19. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
Deswal R; Nanda S; Dang AS
Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
[TBL] [Abstract][Full Text] [Related]
20. Polymorphic variation in the androgen receptor gene: association with risk of testicular germ cell cancer and metastatic disease.
Västermark Å; Giwercman YL; Hagströmer O; Rajpert De-Meyts E; Eberhard J; Ståhl O; Cedermark GC; Rastkhani H; Daugaard G; Arver S; Giwercman A
Eur J Cancer; 2011 Feb; 47(3):413-9. PubMed ID: 20880698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
